Tonix enters into worldwide licensing agreement with OyaGen to develop TNX-3500 for COVID-19 April 20, 2021
Context Therapeutics and Integral Molecular collaborate to develop novel anti-CLDN6 antibodies April 12, 2021
Alkermes collaborates with MSD to evaluate nemvaleukin alfa in combination with Keytruda April 8, 2021
Advaxis and Columbia University Irving Medical Center enter agreement on phase I study of ADXS-504 April 6, 2021
ChromaDex announces research initiative to study effects of Niagen and citrin deficiency March 31, 2021
RSS